↓ Skip to main content

Phase 1 study of TAS-102 administered once daily on a 5-day-per-week schedule in patients with solid tumors

Overview of attention for article published in Investigational New Drugs, June 2008
Altmetric Badge

Mentioned by

patent
10 patents

Citations

dimensions_citation
70 Dimensions

Readers on

mendeley
30 Mendeley
Title
Phase 1 study of TAS-102 administered once daily on a 5-day-per-week schedule in patients with solid tumors
Published in
Investigational New Drugs, June 2008
DOI 10.1007/s10637-008-9142-3
Pubmed ID
Authors

Michael J. Overman, Gauri Varadhachary, Scott Kopetz, Melanie B. Thomas, Masakazu Fukushima, Keizo Kuwata, Akira Mita, Robert A. Wolff, Paulo M. Hoff, Henry Xiong, James L. Abbruzzese

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 30 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 1 3%
Unknown 29 97%

Demographic breakdown

Readers by professional status Count As %
Researcher 9 30%
Student > Master 4 13%
Student > Doctoral Student 3 10%
Other 3 10%
Student > Postgraduate 3 10%
Other 4 13%
Unknown 4 13%
Readers by discipline Count As %
Medicine and Dentistry 15 50%
Biochemistry, Genetics and Molecular Biology 2 7%
Chemistry 2 7%
Nursing and Health Professions 2 7%
Agricultural and Biological Sciences 2 7%
Other 2 7%
Unknown 5 17%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 28 March 2023.
All research outputs
#7,722,978
of 23,485,204 outputs
Outputs from Investigational New Drugs
#341
of 1,196 outputs
Outputs of similar age
#29,151
of 83,633 outputs
Outputs of similar age from Investigational New Drugs
#3
of 7 outputs
Altmetric has tracked 23,485,204 research outputs across all sources so far. This one is in the 44th percentile – i.e., 44% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,196 research outputs from this source. They receive a mean Attention Score of 4.8. This one is in the 42nd percentile – i.e., 42% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 83,633 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 18th percentile – i.e., 18% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 7 others from the same source and published within six weeks on either side of this one. This one has scored higher than 4 of them.